References
- Kennedy L., Sahn S. A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 1994; 106: 1215–1222
- Viallat J. R., Rey F., Astoul P., Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest 1996; 110: 1387–1393
- Heffner J. E., Standerfer R. J., Torstveit J., Unruh L. Clinical efficacy of doxycycline for pleurodesis. Chest 1994; 105: 1743–1747
- Sahn S. A., Light R. W. Pro/Con editorials: talc should be used for pleurodesis/talc should not be used for pleurodesis. Am. J. Respir. Crit. Care Med. 2000; 162: 2023–2026
- Rinaldo J. E., Owens G. R., Rogers R. M. Adult respiratory distress syndrome following intrapleural administration of talc. J. Thorac. Cardiovasc. Surg. 1983; 85: 523–526
- Bouchama A., Chastre J., Gaudichet A., Soler P., Gibert C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest 1984; 86: 795–797
- Rehse D. H., Aye R. W., Florence M. G. Respiratory failure following talc pleurodesis. Am. J. Surg. 1999; 177: 437–440
- Campos J. R., Werebe E. C., Vargas F. S., Jatene F. B., Light R. W. Respiratory failure due to insufflated talc. Lancet 1997; 349: 251–252
- van den Heuvel M. M., Smit H. J., Barbierato S. B., Havenith C. E., Beelen R. H., Postmus P. E. Talc-induced inflammation in the pleural cavity. Eur. Respir. J. 1998; 12(6)1419–1423
- Kennedy L., Harley R. A., Sahn S. A., Strange C. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest 1995; 107: 1707–1712
- Xie C., Texeira L. R., McGovern J. P., Light R. W. Systemic corticosteroids decrease the effectiveness of talc pleurodesis. Am. J. Respir. Crit. Care Med. 1998; 157: 1441–1444
- Weissberg D., Ben-Zeev I. Talc pleurodesis. Experience with 360 cases. J. Thorac. Cardiovasc. Surg. 1993; 106: 689–695
- Werebe E. C., Pazetti R., Milanez de Campos J. R., Fernandez P. P., Capelozzi V. L., Jatene F. B., Vargas F. S. Systemic distribution of talc after intrapleural administration in rats. Chest 1999; 115: 190–193